))
ActiPulse Neuroscience
Manage episode 313759404 series 3285120
Inhoud geleverd door Alex Rochegude. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Alex Rochegude of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
In this episode, Alex Rochegude, Cofounder of Predictiv, invited Adrien Chatillon to discuss about a new generation of medical treatments for Brain Diseases.
Adrien is a serial entrepreneur, and the CEO and cofounder of Actipulse Neuroscience, a medical company specialized in Non-Invasive Brain Stimulation therapeutics for the treatment of Major Depressive Disorder, and that is also under clinical trials for Alzheimer's Disease and post-stroke rehabilitation. Actipulse Neuroscience has already treated more than 11,000 patients in the past two years for Major Depressive Disorders, and has an objective of reaching 100,000 patients by 2025.
--- Send in a voice message: https://podcasters.spotify.com/pod/show/thefutureofhealth/message6 afleveringen
Delen
